Smooth Drug Development – e-PRO – CRO in Russia, CIS and Baltic States

e-PRO

The use of electronic diaries is supported by scientific research that shows memory recall of an event is often unreliable and laden with inaccuracies, further supporting the use of e-PRO (Electronic Patient Reported Outcomes) versus traditional paper diaries.
In 2016 Smooth Drug Development team designed electronic diaries to engage patients to submit time sensitive health information while they go about their daily routines.
e-PRO has huge advantages over paper questionnaires:

Feature

e-PRO

Paper diary

Diary completion reminder

Data verification (automatic edit checks)

Control over data entry time interval

Availability of necessary questionnaires during corresponding study visits

Control over retrospective completion of the diary

Control over skipped items

Availability of data in real time to vital compliance information

Constant data archiving on the central server

Track changes and accurate timestamps

Privacy

Automatic data merge with Clinical Study Database

Smooth uses specially designed Tablet or Mobile phone devices for instant data capture and transfer to a centralized data center.
Smooth e-PRO features include:
  • User friendly
  • BYOD (bring your own device) or given devices depending on project features
  • Automatic data transfer to the study site
  • Easy to use navigation screens
  • Secure – SSL Encrypted Communication
  • Controlled by central management servers
  • No data stored on the device itself
  • Instant access to e-Diary data
We have successfully performed multiple clinical trials using e-PRO. E-PRO enabled us to collect data from hundreds of patients in a short period of time and make objective assessment. 
E-PRO enables us to conduct smaller and what is more important conclusive studies due to a smaller variance of data from e-diaries. 
Studies with e-PRO may result in smaller budget, smaller patient population and possibility to have adaptive trial designs due to up-to-the-minute e-PRO data.